PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH) Financial Statements (2024 and earlier)

Company Profile

Business Address 5910 SOUTH UNIVERSITY BLVD
GREENWOOD VILLAGE, CO 80121
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1161,1143,81125182
Cash and cash equivalents10172025182
Short-term investments151,1073,791   
Receivables264206744 75 
Inventory, net of allowances, customer advances and progress billings4,0144,4494,264111,338 
Inventory4,0144,4494,264111,338 
Prepaid expense      12
Other undisclosed current assets26361327815998 
Total current assets:4,6566,3829,098512,42914
Noncurrent Assets
Operating lease, right-of-use asset3,8653,2423,595 2,173
Property, plant and equipment6,4487,6768,84020477 
Intangible assets, net (including goodwill)3,0142,1892,250 2,147 
Goodwill3,0142,1892,189   
Intangible assets, net (excluding goodwill)   61 2,147 
Other undisclosed noncurrent assets     2,572 
Total noncurrent assets:13,32713,10714,685207,370 
TOTAL ASSETS:17,98319,48923,784719,79914
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,6302,6661,6862,7001,8171,037
Interest and dividends payable 521766
Accounts payable    2,0281,442923
Accrued liabilities    62035847
Other undisclosed accounts payable and accrued liabilities4,6302,6661,686   
Deferred revenue     215
Debt  347220696518492
Derivative instruments and hedges, liabilities    2378801,742
Due to related parties9,8726,44250510 
Other undisclosed current liabilities14,8182,1891,7231,22125068
Total current liabilities:19,44815,07410,0714,9054,1913,339
Noncurrent Liabilities
Long-term debt and lease obligation   3,3472051,927100
Long-term debt, excluding current maturities    205100100
Liabilities, other than long-term debt6,8276,5603,263   
Due to related parties3,5733,263   
Other liabilities3,573     
Operating lease, liability3,2542,9873,347 1,827
Total noncurrent liabilities:6,8276,5606,6102051,927100
Total liabilities:26,27521,63416,6815,1106,1173,439
Equity
Equity, attributable to parent, including:(8,291)(2,145)7,102(3,258)4,219(3,425)
Common stock211641
Common stock, share subscribed but unissued, subscriptions receivable    (0)(0) 
Additional paid in capital25,62823,76123,86527,48625,3437,111
Accumulated deficit(33,923)(25,908)(16,765)(30,384)(21,129)(10,538)
Other undisclosed equity, attributable to parent111(365)11
Equity, attributable to noncontrolling interest    (2,018)(537) 
Other undisclosed equity    238  
Total equity:(8,291)(2,145)7,102(5,039)3,682(3,425)
TOTAL LIABILITIES AND EQUITY:17,98319,48923,784719,79914

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues2,3851,6272,0602,071346 
Loss on disposition of assets for financial service operations(539) (297)   
Cost of revenue(1,263)(1,231)(1,519)(2,302)(1,939) 
Cost of goods and services sold    (2,720)(2,046) 
Other undisclosed gross profit    (418)(107) 
Gross profit:1,122396541(649)(1,700) 
Operating expenses(6,668)(6,049)(6,478)(9,906)(9,178)(2,436)
Operating loss:(5,546)(5,652)(5,937)(10,555)(10,878)(2,436)
Nonoperating income (expense)(2,469)(3,490)1,155(387)654(1,901)
Investment income, nonoperating178232237   
Other nonoperating income (expense)    (387)654(1,901)
Interest and debt expense16827561263,005(464)
Loss from continuing operations before equity method investments, income taxes:(8,015)(8,461)(4,027)(10,815)(7,220)(4,802)
Other undisclosed income (loss) from continuing operations before income taxes(1)(682)(756)(126)(3,005)464
Loss from continuing operations:(8,015)(9,143)(4,782)(10,941)(10,225)(4,337)
Loss before gain (loss) on sale of properties:(4,782)(10,941)(10,225)(4,337)
Net loss attributable to parent:(8,015)(9,143)(4,782)(10,941)(10,225)(4,337)
Preferred stock dividends and other adjustments     (904) 
Other undisclosed net income available to common stockholders, basic    1,481537 
Net loss available to common stockholders, diluted:(8,015)(9,143)(4,782)(9,461)(10,591)(4,337)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(8,015)(9,143)(4,782)(10,941)(10,225)(4,337)
Comprehensive loss, net of tax, attributable to parent:(8,015)(9,143)(4,782)(10,941)(10,225)(4,337)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: